Recent Press ReleasesApply12.02.2021AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing11.25.2021Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to <12 Years of Age in the European Union11.24.2021Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference11.22.2021Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age11.19.2021Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium11.19.2021Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older11.18.2021Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis11.18.2021Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-1911.17.2021Pfizer Completes Acquisition of Trillium Therapeutics11.17.2021Pfizer Announces Retirement of Chief Financial Officer Frank D’AmelioMedia ContactsGet to Know UsCompany Fact SheetFeatured StoriesPodcastsPress Kits @Pfizer @Pfizer_Newsby pfizerTweets by pfizer_news
